No 340B Savings for Transgender Care Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 11
- Latest action
- Mar 18, 2025
What it does
The bill would prohibit 340B covered entities from using savings generated from the difference between the 340B ceiling price and the actual acquisition cost of outpatient drugs to pay for sex reassignment surgeries or hormone treatments intended for gender alteration in transgender individuals. It amends Section 340B(a)(4) of the Public Health Service Act to add this restriction. The prohibition applies to covered entities participating in the 340B drug pricing program. The bill does not ban these services outright but restricts the use of specific federal drug pricing savings to fund them.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.